Ripoll, G. V., Pifano, M., Garona, J., & Alonso, D. F. (2020). Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Web
Citación estilo ChicagoRipoll, Giselle Vanina, Marina Pifano, Juan Garona, and Daniel Fernando Alonso. Commentary: Arginine Vasopressin Receptor 1a Is a Therapeutic Target for Castration-resistant Prostate Cancer. 2020.
Cita MLARipoll, Giselle Vanina, Marina Pifano, Juan Garona, and Daniel Fernando Alonso. Commentary: Arginine Vasopressin Receptor 1a Is a Therapeutic Target for Castration-resistant Prostate Cancer. 2020.
Precaución: Estas citas no son 100% exactas.